Skip to main content

French study says wine causes cancer

Just when we thought the issue was settled, a new large scale study from France's National Cancer Institute finds that even small amounts of regular drinking can increase the risk of cancer. In fact, even as little as one glass of wine per day supposedly ups the odds of cancers of the throat all the way through to the colon and rectum. Problem is, this study is so out of phase with everything we have been hearing about wine and health that it ends up confusing the issue rather than helping. Here's what I think:
The first key to putting this in context is to remember that cancer isn't the whole story with wine and health. Benefits in lowered cardiovascular disease risk, Alzheimer's, diabetes, osteoporosis, and many others would vastly outweight the increased cancer risk even if it did exist. Secondly, no single study provides the definitive answer; in order for it to be meaningful, it has to be independently confirmed by other studies. This one is inconsistent with nearly every previous study of its type, notably statistics from the American National Cancer Institute. Cancers of the type referenced in the French study are known to have a high association with smoking, and a very large percentage of French drinkers also smoke, so it is impossible to tease out the statistical risk attributable to wine drinking alone with any accuracy.
There was a similar hubbub about a year ago when a large study from Kaiser-Permanente found that even modest consumption of wine increased breast cancer risk. Less noticed was a study from Japan published the same month finding exactly the opposite. I cover the reasons behind this in the next edition of Age Gets Better with Wine.

Comments

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

Should wine labels make health claims?

Winemakers have been in a debate for some years now with the U.S. Department of Treasury's Alcohol, Tax and Trade Bureau (formerly the ATF, for Alcohol, Tobacco, and Firearms--yeah, that made a lot of sense) about ingredient listing for wines, particularly since the healthful properties of wine polyphenols such as resveratrol have been widely publicised. A couple of years back, an Oregon pinot noir producer gained approval for a fairly benign claim: "Pinot noir develops a natural defense against botrytis (mold) in our moist, cool climate - the antioxidant resveratrol." Since resveratrol is indeed produced in the skins of grapes subjected to certain environmental stresses such as mold, and Oregon's climate is certifiably moist, it seems a fairly harmless claim. However, the feds simultaneously disallowed placing the same wording on another vintage from the same producer, citing concern about making therapeutic claims on labels or creating "misleading" associa...